Aptamer-modified Magnetic Nanosensitizer for in vivo MR imaging of HER2-expressing Cancer
Autor: | Dan Heo, Minhee Ku, Jung-Hoon Kim, Jaemoon Yang, Jin-Suck Suh |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: | |
Zdroj: | Nanoscale Research Letters, Vol 13, Iss 1, Pp 1-10 (2018) |
Druh dokumentu: | article |
ISSN: | 1931-7573 1556-276X |
DOI: | 10.1186/s11671-018-2682-3 |
Popis: | Abstract The aim of this study was the development of a human epidermal growth factor receptor 2 (HER2)-targetable contrast agent for magnetic resonance imaging (MRI) with a high magnetic sensitivity. An anti-HER2 aptamer-modified magnetic nanosensitizer (AptHER2-MNS) was prepared by conjugation with 5′-thiol-modified aptamers and maleimidylated magnetic nanocrystals (MNCs). The physicochemical characteristics and targeting ability of AptHER2-MNS were confirmed, and the binding affinity (K d ) onto HER2 protein of AptHER2-MNS was 0.57 ± 0.26 nM. In vivo MRI contrast enhancement ability was also verified at HER2+ cancer cell (NIH3T6.7)-xenograft mouse models (n = 3) at 3T clinical MRI instrument. The control experiment was carried out using non-labeled MNCs. The results indicated that up to 150% contrast enhancement was achieved at the tumor region in the T2-weighted MR images after the injection of the AptHER2-MNS agent in mice that received the NIH3T6.7 cells. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |